Apolipoprotein D

Rassart Figure 1

Rassart Figure 2

Apolipoprotein D (APOD) is a protein that in humans is encoded by the APOD gene. It is a component of high-density lipoprotein (HDL) in the blood plasma and plays a critical role in lipid metabolism, neuroprotection, and oxidative stress. APOD is part of the apolipoprotein family, which is essential for the transport of lipids through the lymphatic system and bloodstream.

Function

Apolipoprotein D is involved in the transport and binding of lipid molecules within the circulatory system, facilitating their movement and utilization throughout the body. It has a high affinity for certain types of lipids, such as arachidonic acid, and is believed to play a role in the brain's response to oxidative stress, neuroprotection, and the repair of neurons. Its expression is upregulated in response to stress and injury, suggesting a protective role in the nervous system.

Structure

The APOD protein is a glycoprotein and is part of the lipocalin family, which transports small hydrophobic molecules. It is characterized by a barrel-shaped tertiary structure that allows it to bind to small lipid molecules. The gene encoding APOD is located on chromosome 3 (3q29) in humans.

Clinical Significance

Elevated levels of APOD have been observed in various diseases and conditions, including neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease, as well as in aging. Its role in these conditions is not fully understood, but it is thought to be related to its functions in lipid transport and neuroprotection. Research suggests that APOD may have potential as a biomarker for certain diseases and as a target for therapeutic interventions.

Research

Ongoing research is focused on elucidating the precise mechanisms by which APOD contributes to neuroprotection, lipid metabolism, and the response to oxidative stress. Studies are also investigating the potential therapeutic applications of APOD, including its use as a biomarker for early detection of neurodegenerative diseases and as a target for drug development aimed at modulating its expression or function.

‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian